Concepedia

Helen Kotanides

HK

13

Publications

1.2K

Citations

12

H-Index

1993

Active since

Affiliations

Eli Lilly (United States)(Current)

SciClone Pharmaceuticals (United States)

State University of New York

Stony Brook University

Helen Kotanides is an author at Eli Lilly (United States) specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

1993–2020

13

Publications

13

Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase

Simon Rousseau, François Houle, Helen Kotanides et al. · Journal of Biological Chemistry · 2000 · 313 citations · Full text

, , +19

Requirement of Tyrosine Phosphorylation for Rapid Activation of a DNA Binding Factor by IL-4

Helen Kotanides, Nancy C. Reich · Science · 1993 · 254 citations

, , +20

Interleukin-4-induced STAT6 Recognizes and Activates a Target Site in the Promoter of the Interleukin-4 Receptor Gene

Helen Kotanides, Nancy C. Reich · Journal of Biological Chemistry · 1996 · 109 citations · Full text

Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.

Z Zhu, Patricia Rockwell, Dan Lu et al. · PubMed · 1998 · 105 citations

, , +19

DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity

Karen E. Rabenau, Jennifer M. O'Toole, Rajiv Bassi et al. · Oncogene · 2004 · 70 citations

, , +10

Rows per page

1–5 of 13